US2269489A - Contrast agent for X-ray diagnoses - Google Patents

Contrast agent for X-ray diagnoses Download PDF

Info

Publication number
US2269489A
US2269489A US234403A US23440338A US2269489A US 2269489 A US2269489 A US 2269489A US 234403 A US234403 A US 234403A US 23440338 A US23440338 A US 23440338A US 2269489 A US2269489 A US 2269489A
Authority
US
United States
Prior art keywords
contrast
contrast agent
substances
ray
diagnoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US234403A
Other languages
English (en)
Inventor
Schwenk Erwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of US2269489A publication Critical patent/US2269489A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Definitions

  • Another object of the invention is the visualization of a wider area than hitherto rendered accessible. 4.
  • Still a further objector the invention is to provide for visualizationf over an extended period to facilitate study of the function of the organs.
  • Retrograding pyelography involves cystoscopy and catheterization, contrast substances such as lithium iodide or sodium iodide dissolved in water being introduced, through the catheter, into the bladder and the ureters. To the extent that the substances filled the organs, X-ray pictures showing in outline any irregularities were obtainable.
  • the present invention is based on thev concept that all the drawbacks of the prior methods can be eliminated, and a procedure can be obtained which is generally applicable, i. e. which is operative also under conditions of obstructions or disorders in the anatomical channels, which is available to the general practitioner, which eliminates pain or discomfort on the part of the patient, which results in high" contrast visualization and pictures of the genito-urinary tract, and which increases both the area rendered visible and the period of time during which it is accessible to observation, if the methods of the prior art are critically departed from and a novel method is introduced which provides for the direct introduction of the contrast agent into the general circulation.
  • the most obvious and most effective mode of directly introducing the contrast agent into the circulation is to administer'such substance by way of intravenous injection, and accordingly this is the method contemplated by the present invention.
  • the class of substances thus established is distinguished by a combination of properties common to all its members, as follows: the substances are organic compounds containing iodine or bromine, have the halogen linked to carbon in a stable non-ionizing form, are highly soluble, and are substantially inert with respect to the human v body.
  • the contrast substances employed according to the invention may be characterized as being salts of compounds having the general formula A-B-C, where A constitutes the shadow-forming part of the molecule and comprises an aliphatic or aromatic or pyridine ring substituted by halogen; B constitutes'a link connecting the groups A and C and comprising one or more carbon atoms in a chain, or an oxygen or an amino group, or a combination of several of these; and C constitutes the group responsible'for the high solubility of the compound, particularly in water, and comprises a carboxyl or sulfoxyl group. It is noted that while A and C must always be present, the intermediate link B may be non-existent, its part being taken by part of the group A.
  • a solution of one of the novel contrast agents in water is prepared under sterile conditions, the concentration of the solution being preferably provided as between approximately 40 to
  • the sterile solution is then preferably warmed to body temperature and intravenously injected into the cubital vein.
  • the injection should proceed slow- 1y so as to avoid any discomfort on the part of the patient.
  • After the injection is completed one has to wait for about from 5 to 10 minutes before the first screen observation may be made, or the first picture may be taken in the usual manner. Subsequently, a great number of pictures may be taken at intervals, the next following ones, e. g. after about 30 and '50 minutes.
  • the method is generally applicable, even in cases of obstruction of the channels formerly utilized in retrograding pyelography.
  • the method is available to the general practitioner. In years of experience, the method has been established to eliminate pain or discomfort on the part of the patient. High contrast visualization and pictures are readily obtainable.
  • the area rendered visible is considerably increased when compared with that previously rendered accessible, owing to the utilisation of the entire tract as channel for the agents.
  • the period of time over which visualization may be readily had is likewise considerably increased, the agent being kept in the tract for the length of time taken up by the physiological excretion processes.
  • a contrast agent especially useful for rendering the urogenital system less pervious to X-rays comprising essentially a water-soluble pyridine which comprises rendering the urogenital system less pervious to X-rays, and thereby visible on the screen, by injecting into the blood stream of the patient, and thus conveying through the latter and'to the urogenital system, a solution of a soluble, stable, non-toxic pyridine c-arboxylie-acid salt containing as a further substituent in the nucleus a member of the group consisting of bromine and iodine joined directly to nuclear carlo bon in non-ionizing form.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
US234403A 1929-09-25 1938-10-11 Contrast agent for X-ray diagnoses Expired - Lifetime US2269489A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2269489X 1929-09-25

Publications (1)

Publication Number Publication Date
US2269489A true US2269489A (en) 1942-01-13

Family

ID=7993153

Family Applications (1)

Application Number Title Priority Date Filing Date
US234403A Expired - Lifetime US2269489A (en) 1929-09-25 1938-10-11 Contrast agent for X-ray diagnoses

Country Status (6)

Country Link
US (1) US2269489A (de)
AT (1) AT129942B (de)
CH (1) CH150122A (de)
ES (1) ES119679A1 (de)
FR (1) FR709790A (de)
GB (1) GB361437A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568560A1 (fr) * 1984-07-31 1986-02-07 Wicanders Ab Tete de bouchage pour machine a capsuler des bouteilles

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512014A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Composes bromes utilisables dans des produits opacifiants

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568560A1 (fr) * 1984-07-31 1986-02-07 Wicanders Ab Tete de bouchage pour machine a capsuler des bouteilles

Also Published As

Publication number Publication date
ES119679A1 (es) 1930-10-16
CH150122A (de) 1930-10-15
AT129942B (de) 1932-10-10
GB361437A (en) 1931-11-26
FR709790A (fr) 1931-08-13

Similar Documents

Publication Publication Date Title
Romero-Castro et al. EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos)
Alavi et al. Scintigraphic detection of acute gastrointestinal bleeding
US10350310B2 (en) Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition
Binmoeller et al. Endoscopic management of postoperative biliary leaks: review of 77 cases and report of two cases with biloma formation.
BAUM et al. Selective arteriography in the diagnosis of hemorrhage in the gastrointestinal tract
Kosuda et al. Uptake of 2-deoxy-2-[18F] fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment
SIDDIQUI et al. Comparison of technetium-99m sulfur colloid and in vitro labeled technetium-99m RBCs in the detection of gastrointestinal bleeding
Alavi Scintigraphic demonstration of acute gastrointestinal bleeding
ES2259299T3 (es) Uso de agentes de contraste en la fabricacion de agentes de diagnostico para la visualizacion del lumen intestinal.
Matikainen et al. Duodenogastric reflux in patients with heartburn and oesophagitis
Taylor et al. Angiographic visualization of the secretin-stimulated pancreas
Berger et al. Slowing of hepatic blood flow by halothane: angiographic manifestations
Burwood et al. Endoscopic Retrograde Choledocho-Pancreatography: A review with a report of a collaborative series
CRAWFORD et al. Jejunoileal arteriovenous malformation: localization for resection by segmental bowel staining techniques
Hiramatsu et al. Selective intraarterial steroid injection in ulcerative colitis
Novick et al. Digital subtraction angiography for postoperative evaluation of renal arterial reconstruction
Steckel et al. A potent drug combination for producing constriction of the superior mesenteric artery and its branches
Bron et al. The value of selective arteriography in demonstrating portal and splenic vein patency following nonvisualization by splenoportography
JP3714972B2 (ja) 病変組織異常血管の注射用止血剤
Ryan Eosinophilic infiltration of duodenum and pancreatic head: report of a case studied arteriographically
Acker et al. Selective celiac angiography
Freed et al. Effects of intra-arterial acetylcholine on renal arteriography in normal humans
Rosen et al. Retrograde Pancreatic Venography: An Experimental Study
Piccone et al. Angial residue hepatography versus direct transumbilical hepatography: A comparison of two new methods
SU724126A1 (ru) Способ экскреторной урографии при почечной колике